Personal record-keeping and educational reference. 18+. The app does not recommend substances, doses or treatment, or determine whether a substance is safe, approved or appropriate for you. Consult a qualified healthcare professional about decisions involving your health.
‹ Library

FOXO4-DRI

Longevity & Anti-AgingResearch Use Only

Also known as: FOXO4 D-Retro-Inverso peptide, Proxofim

An experimental 'senolytic' peptide designed to clear worn-out (senescent) cells — no human safety data yet.

Dosing quick reference

research reference
Starting dose
250 mcg once daily
Frequency
Once daily
Typical range
250–500 mcg per day
Cycle
8–16 weeks
Titration (step-up)
Wk 1–4: 250 → Wk 5–8: 375 → Wk 9+: 500 mcg
No human clinical data exist.
Half-life
Not well characterized
Route
Subcutaneous / intraperitoneal (research)
Common use
Longevity / senescent-cell (senolytic) research
Common vial sizes
10 mg
Storage
Store lyophilized powder frozen and protected from light; once reconstituted, refrigerate and use promptly
Regulatory note: Not approved as a drug in Canada or the US; research-use-only and studied only in preclinical settings.
Calculate a dose →FOXO4-DRI on The Peptide Guide →Deeper research reference: literature dose ranges, storage and handling, and where to source in Canada.

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Research-only labeling does not establish that a substance is safe, approved or appropriate for personal use. Consult a qualified healthcare professional about health decisions.